New Swiss Home Dialysis System Receives Marketing Approval

Updated: 4 days ago


The Peripal team is delighted, that after intensive development in collaboration with ETH Zurich and genuine PD patients, the PeriSafe® device for patients with peritoneal dialysis has received approval for the European market. The PeriSafe® device can be used in PD patients as of now, this can help more patients to undergo home dialysis treatments and can lower healthcare costs.


New Swiss Home Dialysis System Receives Marketing Approval: PeriSafe® Helps Thousands of Chronically Ill Kidney Patients With Peritoneal Dialysis. It lowers healthcare costs and improves the quality of life for those affected.


The Swiss medtech startup Peripal AG introduces an innovative auxiliary device for peritoneal dialysis patients. After successfully developing the device in collaboration with ETH Zurich, Peripal AG received the seal of approval to introduce it on the European market. Now patients can undergo home dialysis treatments both more safely and more easily.


Read more below

20190327_Press release-Market approval_F
.
Download • 125KB


March 27, 2019


#healthcare #dialysis #homecare #covid #patient #medical #patientcare #hospitals #dialyse #nephrology #dialysis #endstagekidneydisease #chronickidneydisease #kidneydialysis #femaleempowerment #peritonealdialysis #peripal #perisafe

2 views

Peripal AG

Limmatquai 112

8001 Zurich

Switzerland

info@peripal.com

Tel.: +41 44 221 95 40

© 2020 by Peripal AG